Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation

F. Caprioli, C. Stolfi, R. Caruso, D. Fina, G. Sica, L. Biancone, F. Pallone, G. Monteleone

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective: Defects in Fas-mediated apoptosis are supposed to contribute to the accumulation of T lymphocytes in the gut of patients with Crohn's disease (CD). This phenomenon has been functionally linked with the elevated expression of Flip, an inhibitor of Fas-mediated apoptosis. In this study, the molecular mechanisms that control Flip in CD were examined. Methods: Paired colonic biopsies of patients with CD, patients with ulcerative colitis (UC) and normal controls were analysed for Flip by real-time PCR and western blotting. Flip was also evaluated in CD3+ lamina propria lymphocytes (T-LPLs) cultured with tosyl phenylalanyl chloromethyl ketone (TPCK; a nuclear factor-κB (NF-κB) inhibitor), AG490 (a Janus kinase 2 (Jak2)/signal transducer and activator of transcription (Stat) inhibitor) or 17-desmethoxy-17-N,N- dimethylamino-geldanamycin (DMAG; an inhibitor of heat shock protein 90). The rate of apoptosis was examined by flow cytometry. Results: In CD, upregulation of Flip occurred at both the RNA and protein level. Treatment of CD CD3 + T-LPLs with TPCK or AG490 markedly reduced Flip RNA, suggesting a role for NF-κB and Jak/Stat pathways in the transcriptional control of Flip in this condition. Consistently, both TPCK and AG490 sensitised CD T-LPLs to Fas-mediated apoptosis. Flip protein in cells from normal gut was rapidly degraded by the proteasome pathway. In contrast, in inflamed gut of both CD and UC patients, there was a reduced degradation of Flip via the ubiquitin-proteasome-dependent pathway, but Flip expression can be decreased by DMAG. Conclusions: The data demonstrate that Flip is regulated at both the transcriptional and post-translational level in CD, and indicate that in the normal but not inflamed gut Flip is degraded via the ubiquitin-proteasome- dependent pathway.

Original languageEnglish
Pages (from-to)1674-1680
Number of pages7
JournalGut
Volume57
Issue number12
DOIs
Publication statusPublished - Dec 2008

Fingerprint

Crohn Disease
Apoptosis
Inflammation
Tosylphenylalanyl Chloromethyl Ketone
Proteasome Endopeptidase Complex
Ubiquitin
Transducers
Ulcerative Colitis
Janus Kinase 2
RNA
HSP90 Heat-Shock Proteins
Ketones
Real-Time Polymerase Chain Reaction
Flow Cytometry
Mucous Membrane
Proteins
Up-Regulation
Western Blotting
Lymphocytes
T-Lymphocytes

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation. / Caprioli, F.; Stolfi, C.; Caruso, R.; Fina, D.; Sica, G.; Biancone, L.; Pallone, F.; Monteleone, G.

In: Gut, Vol. 57, No. 12, 12.2008, p. 1674-1680.

Research output: Contribution to journalArticle

Caprioli, F, Stolfi, C, Caruso, R, Fina, D, Sica, G, Biancone, L, Pallone, F & Monteleone, G 2008, 'Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation', Gut, vol. 57, no. 12, pp. 1674-1680. https://doi.org/10.1136/gut.2008.149286
Caprioli, F. ; Stolfi, C. ; Caruso, R. ; Fina, D. ; Sica, G. ; Biancone, L. ; Pallone, F. ; Monteleone, G. / Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation. In: Gut. 2008 ; Vol. 57, No. 12. pp. 1674-1680.
@article{59a305a15f5247cf86bd72cbece6e2c9,
title = "Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation",
abstract = "Objective: Defects in Fas-mediated apoptosis are supposed to contribute to the accumulation of T lymphocytes in the gut of patients with Crohn's disease (CD). This phenomenon has been functionally linked with the elevated expression of Flip, an inhibitor of Fas-mediated apoptosis. In this study, the molecular mechanisms that control Flip in CD were examined. Methods: Paired colonic biopsies of patients with CD, patients with ulcerative colitis (UC) and normal controls were analysed for Flip by real-time PCR and western blotting. Flip was also evaluated in CD3+ lamina propria lymphocytes (T-LPLs) cultured with tosyl phenylalanyl chloromethyl ketone (TPCK; a nuclear factor-κB (NF-κB) inhibitor), AG490 (a Janus kinase 2 (Jak2)/signal transducer and activator of transcription (Stat) inhibitor) or 17-desmethoxy-17-N,N- dimethylamino-geldanamycin (DMAG; an inhibitor of heat shock protein 90). The rate of apoptosis was examined by flow cytometry. Results: In CD, upregulation of Flip occurred at both the RNA and protein level. Treatment of CD CD3 + T-LPLs with TPCK or AG490 markedly reduced Flip RNA, suggesting a role for NF-κB and Jak/Stat pathways in the transcriptional control of Flip in this condition. Consistently, both TPCK and AG490 sensitised CD T-LPLs to Fas-mediated apoptosis. Flip protein in cells from normal gut was rapidly degraded by the proteasome pathway. In contrast, in inflamed gut of both CD and UC patients, there was a reduced degradation of Flip via the ubiquitin-proteasome-dependent pathway, but Flip expression can be decreased by DMAG. Conclusions: The data demonstrate that Flip is regulated at both the transcriptional and post-translational level in CD, and indicate that in the normal but not inflamed gut Flip is degraded via the ubiquitin-proteasome- dependent pathway.",
author = "F. Caprioli and C. Stolfi and R. Caruso and D. Fina and G. Sica and L. Biancone and F. Pallone and G. Monteleone",
year = "2008",
month = "12",
doi = "10.1136/gut.2008.149286",
language = "English",
volume = "57",
pages = "1674--1680",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",
number = "12",

}

TY - JOUR

T1 - Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation

AU - Caprioli, F.

AU - Stolfi, C.

AU - Caruso, R.

AU - Fina, D.

AU - Sica, G.

AU - Biancone, L.

AU - Pallone, F.

AU - Monteleone, G.

PY - 2008/12

Y1 - 2008/12

N2 - Objective: Defects in Fas-mediated apoptosis are supposed to contribute to the accumulation of T lymphocytes in the gut of patients with Crohn's disease (CD). This phenomenon has been functionally linked with the elevated expression of Flip, an inhibitor of Fas-mediated apoptosis. In this study, the molecular mechanisms that control Flip in CD were examined. Methods: Paired colonic biopsies of patients with CD, patients with ulcerative colitis (UC) and normal controls were analysed for Flip by real-time PCR and western blotting. Flip was also evaluated in CD3+ lamina propria lymphocytes (T-LPLs) cultured with tosyl phenylalanyl chloromethyl ketone (TPCK; a nuclear factor-κB (NF-κB) inhibitor), AG490 (a Janus kinase 2 (Jak2)/signal transducer and activator of transcription (Stat) inhibitor) or 17-desmethoxy-17-N,N- dimethylamino-geldanamycin (DMAG; an inhibitor of heat shock protein 90). The rate of apoptosis was examined by flow cytometry. Results: In CD, upregulation of Flip occurred at both the RNA and protein level. Treatment of CD CD3 + T-LPLs with TPCK or AG490 markedly reduced Flip RNA, suggesting a role for NF-κB and Jak/Stat pathways in the transcriptional control of Flip in this condition. Consistently, both TPCK and AG490 sensitised CD T-LPLs to Fas-mediated apoptosis. Flip protein in cells from normal gut was rapidly degraded by the proteasome pathway. In contrast, in inflamed gut of both CD and UC patients, there was a reduced degradation of Flip via the ubiquitin-proteasome-dependent pathway, but Flip expression can be decreased by DMAG. Conclusions: The data demonstrate that Flip is regulated at both the transcriptional and post-translational level in CD, and indicate that in the normal but not inflamed gut Flip is degraded via the ubiquitin-proteasome- dependent pathway.

AB - Objective: Defects in Fas-mediated apoptosis are supposed to contribute to the accumulation of T lymphocytes in the gut of patients with Crohn's disease (CD). This phenomenon has been functionally linked with the elevated expression of Flip, an inhibitor of Fas-mediated apoptosis. In this study, the molecular mechanisms that control Flip in CD were examined. Methods: Paired colonic biopsies of patients with CD, patients with ulcerative colitis (UC) and normal controls were analysed for Flip by real-time PCR and western blotting. Flip was also evaluated in CD3+ lamina propria lymphocytes (T-LPLs) cultured with tosyl phenylalanyl chloromethyl ketone (TPCK; a nuclear factor-κB (NF-κB) inhibitor), AG490 (a Janus kinase 2 (Jak2)/signal transducer and activator of transcription (Stat) inhibitor) or 17-desmethoxy-17-N,N- dimethylamino-geldanamycin (DMAG; an inhibitor of heat shock protein 90). The rate of apoptosis was examined by flow cytometry. Results: In CD, upregulation of Flip occurred at both the RNA and protein level. Treatment of CD CD3 + T-LPLs with TPCK or AG490 markedly reduced Flip RNA, suggesting a role for NF-κB and Jak/Stat pathways in the transcriptional control of Flip in this condition. Consistently, both TPCK and AG490 sensitised CD T-LPLs to Fas-mediated apoptosis. Flip protein in cells from normal gut was rapidly degraded by the proteasome pathway. In contrast, in inflamed gut of both CD and UC patients, there was a reduced degradation of Flip via the ubiquitin-proteasome-dependent pathway, but Flip expression can be decreased by DMAG. Conclusions: The data demonstrate that Flip is regulated at both the transcriptional and post-translational level in CD, and indicate that in the normal but not inflamed gut Flip is degraded via the ubiquitin-proteasome- dependent pathway.

UR - http://www.scopus.com/inward/record.url?scp=56549101145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56549101145&partnerID=8YFLogxK

U2 - 10.1136/gut.2008.149286

DO - 10.1136/gut.2008.149286

M3 - Article

VL - 57

SP - 1674

EP - 1680

JO - Gut

JF - Gut

SN - 0017-5749

IS - 12

ER -